title: Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections?
authors.forename: P
authors.initials: P
authors.lastname: Viale
authors.forename: N
authors.initials: N
authors.lastname: Petrosillo
authors.forename: L
authors.initials: L
authors.lastname: Signorini
authors.forename: M
authors.initials: M
authors.lastname: Puoti
authors.forename: G
authors.initials: G
authors.lastname: Carosi
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy* / Q000209:etiology; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002675:Child, Preschool; D005260:Female; D016469:Fungemia / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male
chemical_list: D000900:Anti-Bacterial Agents